🌍·6d agoResearch
Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies.
Publisher
E
Europe PMC
EU
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- Europe PMC
- Region
- EU
- Scope
- Research
- Published
- June 29, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on europepmc.org
Leave the platform to read the original full article on the publisher site.
Source: Europe PMC
Scope: Research
Related coverage
More related coverage
Crossref/15h ago
Three-Dimensional Preoperative Planning in Reverse Shoulder Arthroplasty: A Systematic Review of Implant Positioning Accuracy and Clinical Outcomes
Crossref/15h ago
Metabolomic Biomarkers for the Early Detection of Infectious Diseases: A Systematic Review and Meta-Analysis of Diagnostic Performance and Clinical Utility
Crossref/15h ago
Colistin Resistance in Klebsiella pneumoniae: Mechanisms, Detection, and Clinical Impact
Crossref/15h ago